Related Experiment Videos
[Microbiological aspects of antibiotics with immunomodulating action]
G C Schito1, E A Debbia, G Nicoletti
1Istituto di Microbiologia, Università di Genova.
Journal of Chemotherapy (Florence, Italy)
|August 1, 1994
Summary
Cefodizime, a novel cephalosporin, demonstrates potent antimicrobial activity and immunomodulatory properties. It shows stability against common beta-lactamases and efficacy against nosocomial infections.
Area of Science:
- Microbiology
- Pharmacology
- Immunology
Background:
- Cefodizime, a cephalosporin analog of cefotaxime, possesses unique immunomodulatory properties.
- Its structure facilitates bacterial cell wall penetration and rapid induction of cell death and lysis.
Purpose of the Study:
- To evaluate the antimicrobial spectrum and stability of cefodizime against beta-lactamases.
- To assess the in vitro efficacy of cefodizime in treating nosocomial infections.
Main Methods:
- In vitro susceptibility testing against a panel of bacterial pathogens.
- Comparative study against other antibiotics including amoxicillin-clavulanate, gentamicin, and piperacillin.
- Evaluation of stability against prevalent beta-lactamase enzymes (TEM-1, TEM-2, SHV-1, BRO-1).
Main Results:
- Cefodizime exhibits broad-spectrum activity against Enterobacteria, Neisseriae, Haemophilus, Moraxella catarrhalis, methicillin-susceptible staphylococci, and streptococci.
- It is stable against common beta-lactamases but susceptible to some extended-spectrum beta-lactamases.
- In vitro, cefodizime was more effective than amoxicillin-clavulanate, gentamicin, and piperacillin against nosocomial strains.
Conclusions:
- Cefodizime is a potent antimicrobial agent with favorable immunomodulatory effects.
- Its stability against common beta-lactamases and broad spectrum of activity make it a promising option for nosocomial infections.
- Further clinical studies are warranted to confirm its therapeutic potential.